April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Calpain Inhibition Confers Histological and Functional Neuroprotection to Retinal Ganglion Cells in Experimental Optic Neuritis
Author Affiliations & Notes
  • A. W. Smith
    Neuroscience, Medical University of South Carolina, Charleston, South Carolina
  • J. T. Butler
    Neuroscience, Medical University of South Carolina, Charleston, South Carolina
  • B. Rohrer
    Ophthalmology, Med Univ of South Carolina, Charleston, South Carolina
  • M. Azuma
    Senju Laboratory of Ocular Sciences, Senju Pharmaceutical Co Ltd, Kobe, Japan
  • J. Inoue
    Senju USA Inc, Woodland Hills, California
  • N. L. Banik
    Neurology, Medical Univ of South Carolina, Charleston, South Carolina
  • Footnotes
    Commercial Relationships  A.W. Smith, None; J.T. Butler, None; B. Rohrer, None; M. Azuma, None; J. Inoue, None; N.L. Banik, None.
  • Footnotes
    Support  NIH Grants NS056176 and NS041088
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 821. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. W. Smith, J. T. Butler, B. Rohrer, M. Azuma, J. Inoue, N. L. Banik; Calpain Inhibition Confers Histological and Functional Neuroprotection to Retinal Ganglion Cells in Experimental Optic Neuritis. Invest. Ophthalmol. Vis. Sci. 2010;51(13):821.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Optic neuritis (ON), inflammation of the optic nerve, is primarily due to influx of auto-reactive T cells and is manifested by visual dysfunction. Decreased amplitude of visual evoked potential (VEP) and pattern electroretinogram (PERG) responses in patients indicates degeneration of the optic nerve with subsequent retinal damage, respectively. We previously detected increased activity of calpain, a Ca2+-activated protease, in optic nerves and retinas of experimental autoimmune encephalomyelitis (EAE) animals. The roles of calpain in T cell chemotaxis, demyelination, and axonal degeneration are well established. Thus, we hypothesized that retrograde retinal ganglion cell (RGC) death will occur during EAE-induced ON, accompanied by loss of visual function, and early calpain inhibition will confer functional rescue.

Methods: : B10.PL mice were immunized subcutaneously with an emulsion of complete Freund's adjuvant and myelin basic protein. Treated ON mice received twice daily oral dosing of 25mg/kg SNJ-1945 from day 9 post-induction until day 35. PERG analysis and enucleation of eyes for immunohistochemistry was executed on day 35.

Results: : PERG P1 amplitudes in response to a sinusoidal grating of low spatial (0.1c/d) and temporal (1Hz) frequency were compared. While amplitudes were markedly reduced in EAE mice treated with vehicle (2.1µV) when compared to control animals (4.7µV; P<0.05), EAE animals treated with SNJ-1945 were significantly protected (3.8µV; P<0.05). The number of TUNEL+ cells in the RGC layer was increased in ON-vehicle versus control and ON-treated retinas. IHC revealed milder astrogliosis (GFAP), increased numbers of oligodendrocytes (MOSP), and a decreased deNFP/NFP ratio in SNJ-1945-treated nerves compared to vehicle-treated nerves.

Conclusions: : Daily oral dosing of calpain inhibitor protects RGCs in EAE-induced ON. Current inhibitor studies are assessing daily visual function of control and treated mice. We are also examining the mechanisms by which calpain inhibition is modifying the immune cell response in this model.

Keywords: retina: neurochemistry • autoimmune disease 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×